Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases
Authors
Keywords
-
Journal
Current Cardiology Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-24
DOI
10.1007/s11886-023-01961-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
- (2023) Connie W. Tsao et al. CIRCULATION
- The role of obesity-related cardiovascular remodelling in mediating incident cardiovascular outcomes: a population-based observational study
- (2023) Liliana Szabo et al. European Heart Journal-Cardiovascular Imaging
- Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial
- (2023) Hertzel C. Gerstein et al. CIRCULATION
- Longitudinal Hemodynamic Correlates of and Sex Differences in the Evolution of Blood Pressure Across the Adult Lifespan: The Framingham Heart Study
- (2023) Gary F. Mitchell et al. Journal of the American Heart Association
- Body Composition and Risk of Incident Heart Failure in 1 Million Adults: A Systematic Review and Dose–Response Meta‐Analysis of Prospective Cohort Studies
- (2023) Ayodipupo S. Oguntade et al. Journal of the American Heart Association
- Sex‐Specific Risk Factors for Deep Venous Thrombosis and Pulmonary Embolism in a Population‐Based Historical Cohort Study of Middle‐Aged and Older Individuals
- (2023) Annie Brink et al. Journal of the American Heart Association
- Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes
- (2023) Utibe R. Essien et al. JAMA Network Open
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
- (2023) Salim S. Virani et al. CIRCULATION
- The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study
- (2023) Tobias Frischmuth et al. THROMBOSIS AND HAEMOSTASIS
- Sodium‐Glucose Cotransporter‐2 Inhibitors and Primary Prevention of Atherosclerotic Cardiovascular Disease: A Meta‐Analysis of Randomized Trials and Systematic Review
- (2023) Hammad Rahman et al. Journal of the American Heart Association
- Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association
- (2022) Joshua J. Joseph et al. CIRCULATION
- Trajectories of Blood Pressure in Midlife Women: Does Menopause Matter?
- (2022) Saad Samargandy et al. CIRCULATION RESEARCH
- Heart Failure Subtypes and Cardiomyopathies in Women
- (2022) Ersilia M. DeFilippis et al. CIRCULATION RESEARCH
- Arterial Stiffness and Long-Term Risk of Health Outcomes: The FHS
- (2022) Ramachandran S. Vasan et al. HYPERTENSION
- Social determinants of health and obesity: Findings from a national study of US adults
- (2022) Zulqarnain Javed et al. Obesity
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- (2022) Paul A. Heidenreich et al. CIRCULATION
- Effect of weight loss on recurrence of atrial fibrillation after ablative therapy: a systematic review and meta-analysis
- (2022) Dae Yong Park et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on
- (2022) Chrysoula Boutari et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Association between maternal adiposity measures and adverse maternal outcomes of pregnancy: Systematic review and meta‐analysis
- (2022) Nicola Heslehurst et al. Obesity Reviews
- National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020
- (2022) Rishav Adhikari et al. Journal of the American Heart Association
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
- (2022) Muthiah Vaduganathan et al. LANCET
- Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
- (2022) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emerging vascular cell-specific roles for mineralocorticoid receptor: implications for understanding sex differences in cardiovascular disease
- (2022) Nicole L. Wolter et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes
- (2022) Nikolaus Marx et al. CIRCULATION
- Obesity Management in Women of Reproductive Age
- (2021) S. Michelle Ogunwole et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity
- (2021) Thomas A. Wadden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular and Metabolic Outcomes in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized‐Controlled Trials
- (2021) Yao Hao Teo et al. Journal of the American Heart Association
- Sex Differences in Heart Failure With Preserved Ejection Fraction
- (2021) Yohei Sotomi et al. Journal of the American Heart Association
- Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association
- (2021) Nisha I. Parikh et al. CIRCULATION
- Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease:
- (2021) Aristithes G. Doumouras et al. CIRCULATION
- Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
- (2021) Tiffany M. Powell-Wiley et al. CIRCULATION
- Metabolically Healthy/Unhealthy Overweight/Obesity Associations With Incident Heart Failure in Postmenopausal Women
- (2021) Amber R. Cordola Hsu et al. Circulation-Heart Failure
- Risk factors mediating the effect of body mass index and waist-to-hip ratio on cardiovascular outcomes: Mendelian randomization analysis
- (2021) Dipender Gill et al. INTERNATIONAL JOURNAL OF OBESITY
- Adipose tissue estrogen production and metabolism in premenopausal women
- (2021) Natalia Hetemäki et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
- (2021) Birgit Vogel et al. LANCET
- Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined
- (2021) Julie R. Lundgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sex Differences in the Associations of Visceral Adipose Tissue and Cardiometabolic and Cardiovascular Disease Risk: The Framingham Heart Study
- (2021) Andreas A. Kammerlander et al. Journal of the American Heart Association
- Contemporary Medical Management of Peripheral Artery Disease
- (2021) Marc P. Bonaca et al. CIRCULATION RESEARCH
- Obesity-associated cardiovascular risk in women: hypertension and heart failure
- (2021) Jessica L. Faulkner CLINICAL SCIENCE
- Obesity Management in Cardiometabolic Disease: State of the Art
- (2021) Sean J. Iwamoto et al. Current Atherosclerosis Reports
- Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?
- (2021) Abhinav Sharma et al. CURRENT OPINION IN CARDIOLOGY
- Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies
- (2021) Min Seo Kim et al. EUROPEAN HEART JOURNAL
- Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018
- (2021) Li Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
- (2021) Emily Brown et al. LANCET
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
- (2021) Hertzel C. Gerstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Impact of Bariatric Surgery Versus Non-Surgical Treatment on Blood Pressure: Systematic Review and Meta-Analysis
- (2021) Laicheng Wang et al. OBESITY SURGERY
- Digital Peripheral Arterial Tonometry and Cardiovascular Disease Events: The Framingham Heart Study
- (2021) Leroy L. Cooper et al. STROKE
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
- (2021) Michael E. Nassif et al. NATURE MEDICINE
- SGLT inhibitors on weight and body mass: A meta‐analysis of 116 randomized‐controlled trials
- (2021) Alex Jia Yang Cheong et al. Obesity
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
- (2021) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Sex/Gender Differences in Obesity Prevalence, Comorbidities, and Treatment
- (2021) Ashley J. Cooper et al. Current Obesity Reports
- Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018
- (2020) Chintan V. Dave et al. DIABETES CARE
- Sex Differences in Cardiovascular Effectiveness of Newer Glucose‐Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus
- (2020) Valeria Raparelli et al. Journal of the American Heart Association
- Sex Differences in Blood Pressure Trajectories Over the Life Course
- (2020) Hongwei Ji et al. JAMA Cardiology
- Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association
- (2020) Mina K. Chung et al. CIRCULATION
- Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association
- (2020) Laxmi S. Mehta et al. CIRCULATION
- Obesity, Hypertension, and Cardiac Dysfunction
- (2020) Alan J. Mouton et al. CIRCULATION RESEARCH
- Metabolic Inflammation and Insulin Resistance in Obesity
- (2020) Huaizhu Wu et al. CIRCULATION RESEARCH
- Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan
- (2020) Saori Sakaue et al. NATURE MEDICINE
- Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction
- (2020) Isabel T. N. Nguyen et al. PLoS One
- SELECT (Semaglutide effects on cardiovascular outcomes in people with overweight or obesity) rationale and design
- (2020) Donna H. Ryan et al. AMERICAN HEART JOURNAL
- Diabetes, Glycated Hemoglobin, and the Risk of Myocardial Infarction in Women and Men: A Prospective Cohort Study of the UK Biobank
- (2020) Marit de Jong et al. DIABETES CARE
- Age, Sex, and Depot‐Specific Differences in Adipose‐Tissue Estrogen Receptors in Individuals with Obesity
- (2020) Jay W. Porter et al. Obesity
- Relationship between body mass index, risk of venous thromboembolism and pulmonary embolism: A systematic review and dose-response meta-analysis of cohort studies among four million participants
- (2020) Jamal Rahmani et al. THROMBOSIS RESEARCH
- Trends in Obesity Prevalence by Race and Hispanic Origin—1999-2000 to 2017-2018
- (2020) Cynthia L. Ogden et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Benefits and Risks of Bariatric Surgery in Adults
- (2020) David E. Arterburn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure
- (2020) Navin Suthahar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
- (2020) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- The association of amputations and peripheral artery disease in patients with type 2 diabetes mellitus receiving sodium-glucose cotransporter type-2 inhibitors: real-world study
- (2020) Sanjoy K Paul et al. EUROPEAN HEART JOURNAL
- Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction
- (2020) Hidemi Sorimachi et al. EUROPEAN HEART JOURNAL
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- (2020) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options
- (2019) Caroline A. Andrew et al. EXPERT OPINION ON PHARMACOTHERAPY
- Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
- (2019) Bernard Zinman et al. Lancet Diabetes & Endocrinology
- Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity
- (2019) Maria J. Pereira et al. DRUGS
- Sex Differences in Cardiovascular Risk Profile From Childhood to Midlife Between Individuals Who Did and Did Not Develop Diabetes at Follow-up: The Bogalusa Heart Study
- (2019) Tingting Du et al. DIABETES CARE
- Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Co-Transporter 2 Inhibitors for Prevention of MajorAdverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials
- (2019) Thomas A. Zelniker et al. CIRCULATION
- Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta‐analysis of European, North American, and Australian cohorts
- (2019) S Santos et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood
- (2019) Amit V. Khera et al. CELL
- Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals
- (2019) Toshiaki Ohkuma et al. DIABETOLOGIA
- Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index
- (2019) Guo-Chong Chen et al. EUROPEAN HEART JOURNAL
- Progesterone Predisposes Females to Obesity-Associated Leptin-Mediated Endothelial Dysfunction via Upregulating Endothelial MR (Mineralocorticoid Receptor) Expression
- (2019) Jessica L. Faulkner et al. HYPERTENSION
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms by which GLP-1 receptor agonists and SGLT-2 inhibitors reduce cardiovascular risk
- (2019) Abhinav Sharma et al. Canadian Journal of Diabetes
- Complex interaction of obesity, intentional weight loss and heart failure: a systematic review and meta-analysis
- (2019) Rajiv Mahajan et al. HEART
- Sex Differences in Circulating Biomarkers of Cardiovascular Disease
- (2019) Emily S. Lau et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial
- (2019) Ildiko Lingvay et al. Lancet Diabetes & Endocrinology
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Sex Differences in Cardiometabolic Traits and Determinants of Exercise Capacity in Heart Failure With Preserved Ejection Fraction
- (2019) Emily S. Lau et al. JAMA Cardiology
- Body mass index and peripheral artery disease
- (2019) Sean P. Heffron et al. ATHEROSCLEROSIS
- Long-Term Cardiovascular Risk in Women With Hypertension During Pregnancy
- (2019) Michael C. Honigberg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Assessing the Role of Health Behaviors, Socioeconomic Status, and Cumulative Stress for Racial/Ethnic Disparities in Obesity
- (2019) Adolfo G. Cuevas et al. Obesity
- Association of Spontaneous Preterm Delivery and Future Maternal Cardiovascular Disease
- (2018) Margo B. Minissian et al. CIRCULATION
- Differences in Obesity Prevalence by Demographic Characteristics and Urbanization Level Among Adults in the United States, 2013-2016
- (2018) Craig M. Hales et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016
- (2018) Craig M. Hales et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sex Differences in the Impact of Body Mass Index on the Risk of Future Atrial Fibrillation: Insights From the Longitudinal Population‐Based Tromsø Study
- (2018) Jocasta Ball et al. Journal of the American Heart Association
- Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial
- (2018) Bernhard Ludvik et al. Lancet Diabetes & Endocrinology
- The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF
- (2018) Nazir Savji et al. JACC-Heart Failure
- A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss
- (2018) Maria J. Pereira et al. Diabetes Therapy
- A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss
- (2018) Maria J. Pereira et al. Diabetes Therapy
- Liraglutide Treatment Reduces Endothelial Endoplasmic Reticulum Stress and Insulin Resistance in Patients With Diabetes Mellitus
- (2018) Rosa Bretón‐Romero et al. Journal of the American Heart Association
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Body-Weight Fluctuations and Outcomes in Coronary Disease
- (2017) Sripal Bangalore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- The Association Between the Dosage of SGLT2 Inhibitor and Weight Reduction in Type 2 Diabetes Patients: A Meta-Analysis
- (2017) Xiaoling Cai et al. Obesity
- Pregnancy-Related Mortality in the United States, 2011–2013
- (2017) Andreea A. Creanga et al. OBSTETRICS AND GYNECOLOGY
- Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis
- (2017) Chenhan Ma et al. BMJ-British Medical Journal
- Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis
- (2017) Chenhan Ma et al. BMJ-British Medical Journal
- Sex-based differences in myocardial gene expression in recently deceased organ donors with no prior cardiovascular disease
- (2017) Kolsoum InanlooRahatloo et al. PLoS One
- Genetic Obesity and the Risk of Atrial FibrillationClinical Perspective
- (2016) Neal A. Chatterjee et al. CIRCULATION
- Reproductive Risk Factors and Coronary Heart Disease in the Women’s Health Initiative Observational StudyCLINICAL PERSPECTIVE
- (2016) Nisha I. Parikh et al. CIRCULATION
- Risk Factors for Incident Hospitalized Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Postmenopausal WomenClinical Perspective
- (2016) Charles B. Eaton et al. Circulation-Heart Failure
- The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift
- (2016) Filippo Crea et al. EUROPEAN HEART JOURNAL
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort
- (2016) Marc A. Rodger et al. THROMBOSIS RESEARCH
- Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
- (2016) Lancet Diabetes & Endocrinology
- Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus
- (2015) Judith G. Regensteiner et al. CIRCULATION
- Association of Cardiometabolic Multimorbidity With Mortality
- (2015) Emanuele Di Angelantonio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort
- (2015) Rajeev K. Pathak et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
- (2015) Renate B Schnabel et al. LANCET
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sex dimorphism and depot differences in adipose tissue function
- (2013) Ursula A. White et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
- (2013) Michael D. Jensen et al. CIRCULATION
- Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation
- (2013) Hany S. Abed et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
- (2013) Walter J. Paulus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Protein Kinase C-β Contributes to Impaired Endothelial Insulin Signaling in Humans With Diabetes Mellitus
- (2012) Corey E. Tabit et al. CIRCULATION
- Bariatric Surgery and Long-term Cardiovascular Events
- (2012) Lars Sjöström et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Endothelial Function Is Impaired across the Stages of the Menopause Transition in Healthy Women
- (2012) Kerrie L. Moreau et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Relation of Brachial and Digital Measures of Vascular Function in the Community
- (2011) Naomi M. Hamburg et al. HYPERTENSION
- Impact of Abdominal Visceral and Subcutaneous Adipose Tissue on Cardiometabolic Risk Factors: The Jackson Heart Study
- (2010) Jiankang Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Long- and Short-Term Impact of Elevated Body Mass Index on the Risk of New Atrial Fibrillation
- (2010) Usha B. Tedrow et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diet and Lifestyle Risk Factors Associated With Incident Hypertension in Women
- (2009) John P. Forman JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ante- and postnatal risk factors of venous thrombosis: a hospital-based case–control study
- (2008) A. F. JACOBSEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Impact of Gender on the Myocardial Metabolic Response to Obesity
- (2008) Linda R. Peterson et al. JACC-Cardiovascular Imaging
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now